Does aromatase in adipose tissue convert androgens to estradiol and increase with obesity?

Aromatase is the rate-limiting enzyme that catalyzes the conversion of C19 androgens (specifically testosterone and androstenedione) into C18 estrogens (estradiol and estrone). While traditionally associated with the gonads, adipose tissue serves as a primary site for this conversion, particularly in men.

Clinical and effectiveness evidence

In men, peripheral aromatization within adipose tissue accounts for approximately 80% of circulating estrogens. Clinical data consistently demonstrate a strong positive correlation between adiposity and estrogen levels:

• Hormonal Shift: In a study of 1,599 men, increased body mass index (BMI) and waist circumference were significantly associated with higher estradiol levels and lower total testosterone (p < 0.001).
• Depot Differences: Aromatase expression is not uniform across fat depots; visceral adipose tissue (omental fat) often exhibits higher aromatase mRNA levels and enzymatic activity compared to subcutaneous fat, making central obesity a primary driver of hormonal imbalance.
• Suppression of Testosterone: Elevated estradiol from adipose conversion exerts negative feedback on the hypothalamic-pituitary-gonadal (HPG) axis. This suppresses the release of luteinizing hormone (LH), leading to secondary hypogonadism, often referred to as the "obesity-hypogonadal cycle."

Mechanistic explanations

The increase in aromatase activity with obesity is driven by both the volume of adipose tissue and the biochemical environment created by excess fat:

• Transcriptional Upregulation: Aromatase is encoded by the CYP19A1 gene. In lean individuals, its expression in fat is relatively low. However, obesity-induced chronic low-grade inflammation increases levels of pro-inflammatory cytokines such as TNF-α, IL-6, and Interleukin-11.
• Signaling Pathways: These cytokines, along with Prostaglandin E2 (PGE2), activate the JAK/STAT3 and MAPK signaling pathways. These pathways trigger the distal promoters of the CYP19A1 gene, significantly ramping up the production of the aromatase enzyme within adipose stromal cells.
• Leptin Influence: Higher levels of leptin, common in obesity, further stimulate aromatase expression via the p53-HIF1α/PKM2 axis, creating a robust molecular environment for androgen-to-estrogen conversion.

Bottom line

The claim is fully supported by science: adipose tissue is a major site of androgen-to-estradiol conversion, and this enzymatic activity increases proportionally with adiposity. For men, this relationship can lead to a state of functional hypogonadism where excess fat simultaneously lowers testosterone and increases estrogen.